Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids
Clinical trial NCT02379442 · TERMINATED
Trial details
- NCT number
- NCT02379442
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-23
- Primary completion
- 2017-12-13
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.